340B

May 15, 2018
The Senate Health, Education, Labor and Pensions Committee today held the second in a series of hearings examining the 340B drug savings program.   At the hearing, representatives from the Department of Health and Human Services Office of Inspector General and Government Accountability Office…
May 11, 2018
President Trump today unveiled his administration’s blueprint to lower prescription drug prices, which also solicits input on potential actions the Department of Health and Human Services may take to improve competition and negotiation and lower costs. Among other actions, for example, HHS may…
May 22, 2018
AHA today urged the Health Resources and Services Administration to implement without further delay its final regulation on 340B drug ceiling prices and civil monetary penalties for manufacturers. “By failing to implement the final rule, drug manufacturers can continue to overcharge 340B…
May 22, 2018
AHA comments to HRSA regarding proposed rule that would further delay the effective date for implementing final regulations regarding the 340B Drug Pricing Program ceiling price and drug manufacturers’ civil monetary penalties (CMPs) for violations of the ceiling price.
May 15, 2018
More than 60 patients groups yesterday urged Congress to protect the 340B drug savings program. “We stand together to oppose any efforts to diminish the 340B program’s proven ability to help serve vulnerable patients and communities,” wrote the groups. “340B is vital to the health care safety net…
May 15, 2018
AHA Statement before the Senate Committee on Health, Education, Labor and Pensions: Examining Oversight Reports on the 340B Drug Pricing Program
May 14, 2018
The Department of Health and Human Services May 14, issued a policy statement and request for information (RFI) on ways to lower drug prices and reduce out-of-pocket costs for consumers.
May 14, 2018
Another week, another drug industry-funded consultant attempting to divert attention away from the high and rising costs of prescription drugs by attacking the 340B drug pricing program. Such efforts are intended to not only shift attention away from manufacturers’ bad pricing behavior, but also to…
May 11, 2018
Contact:  Marie Johnson, (202) 626-2351                Colin Milligan, (202) 638-5491 Rick Pollack AHA President and CEO May 11, 2018 The AHA applauds President Trump and his administration for taking the initiative to tackle the high price of…
May 7, 2018
Watch the video The timing of the AHA Annual Membership Meeting presents a “real opportunity to talk with your members of Congress about what you are doing back home,” specifically how hospitals are improving value and affordability, coping with escalating drug prices and working at the front…